Cell migration inhibiting compositions and methods and compositions for treating cancer
申请人:Edwards L. David
公开号:US20060128742A1
公开(公告)日:2006-06-15
Methods for treating an individual having cancer are provided. The method may include administering a cell migration inhibitor and a chemotherapeutic agent to the individual to inhibit migration of cancer cell. Inhibiting cell migration may increase cell division. In this manner, the cell migration inhibitor and the chemotherapeutic agent in combination may have increased efficacy compared to the chemotherapeutic agent alone due to the increased cell division. The cell migration inhibitor may include any of the inhibitors described herein. For example, the cell migration inhibitor may be an organic molecule having a molecular weight of less than about 700, a monoclonal antibody, or a natural product.
Liquid-Crystalline Binary Systems with Nonmesomorphic Comb-Shaped Polymer Component
作者:Takenori Kojo、Masanori Nata、Seiji Ujiie
DOI:10.1080/15421406.2012.688618
日期:2012.9.5
Binary liquid-crystalline systems were prepared by mixing a nonmesomorphic comb-shaped polymer (CSP) and low-molecular-weight liquid crystal. CSP exhibited a glass-isotropic phase transition. The binary liquid-crystalline systems consisting of CSP and polar molecule formed smectic A and smectic B phases. The induction of liquid crystalline phases is due to interactions between the side chain of CSP and low-molecular-weight liquid crystals.
SMECTIC A LIQUID CRYSTAL COMPOSITIONS
申请人:MERCK PATENT GmbH
公开号:EP0213146A1
公开(公告)日:1987-03-11
CELL MIGRATION INHIBITING COMPOSITIONS AND METHODS AND COMPOSITIONS FOR TREATING CANCER